CVS Health Corp (CVS) is a publicly traded healthcare plans business based in the US. It opened the day at $86.685 after a previous close of $87.49. During the day the price has varied from a low of $85.46 to a high of $86.97. The latest price was $86.17 (25 minute delay). CVS Health is listed on the NYSE and employs 216,000 staff. All prices are listed in US Dollars.
Best for
0% commission
Best for
Beginner investments
Best for
Beginners
Best for
Mobile app
Both exchange rates and share prices fluctuate in real time, so the costs presented here should be considered as a guide only. They do not incorporate stamp duty. Always refer to the platform itself for availability and pricing – which may differ from our information.
| Platform | Platform fee | Min. initial deposit | Trading fee estimate | |
|---|---|---|---|---|
|
£0 | $50 | £3.52 £706.84 total |
Capital at risk |
|
£0 | £250 | £11.72 £715.04 total |
Capital at risk |
|
£0 | £1 | £3.16 £706.48 total |
Capital at risk |
|
£0 | No minimum | £7.03 £710.35 total |
Capital at risk |
 |
£0 | £1 | £18.98 £722.30 total |
Capital at risk |
 |
£0 | £0.01 | £0.70 £704.02 total |
Capital at risk |
 |
£9.99 per month | No minimum | £18.54 £721.86 total |
Capital at risk |
 |
£36 per year | £20 | £18.29 £721.61 total |
Capital at risk |
 |
£0 | £50 | £3.52 £706.84 total |
Capital at risk |
Full comparison of share dealing platforms
Historical closes compared with the last close of $86.17
| 1 week (2023-01-27) | -1.83% |
|---|---|
| 1 month (2023-01-03) | -7.25% |
| 3 months (2022-11-03) | -11.89% |
| 6 months (2022-08-03) | -15.00% |
| 1 year (2022-02-01) | -18.91% |
|---|---|
| 2 years (2021-02-03) | 17.65% |
| 3 years (2020-02-03) | 28.75% |
| 5 years (2018-02-02) | 12.71% |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page.
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Valuing a stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of overall performance. However, analysts commonly use some key metrics to help gauge value.
CVS Health's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 37x. In other words, CVS Health shares trade at around 37x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
CVS Health's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.3591. A PEG ratio over 1 can be interpreted as meaning shares are overvalued at the current rate of growth, or may anticipate an acceleration in growth.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into CVS Health's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
CVS Health's EBITDA (earnings before interest, taxes, depreciation and amortisation) is a whopping $19.1 billion (£15.6 billion).
The EBITDA is a measure of a CVS Health's overall financial performance and is widely used to measure a its profitability.
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like CVS Health.
CVS Health's total ESG risk: 18.73
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and CVS Health's overall score of 18.73 (as at 01/01/2019) is excellent – landing it in it in the 19th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like CVS Health is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
CVS Health's environmental score: 1.92/100
CVS Health's social score: 9.06/100
CVS Health's governance score: 2.75/100
CVS Health's controversy score: 3/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. A high-profile company, CVS Health scored a 3 out of 5 for controversy – a middle-of-the-table result reflecting that CVS Health hasn't always managed to keep its nose clean.
CVS Health Corp was last rated for ESG on: 2019-01-01.
| Total ESG score | 18.73 |
|---|---|
| Total ESG percentile | 18.84 |
| Environmental score | 1.92 |
| Social score | 9.06 |
| Governance score | 2.75 |
| Level of controversy | 3 |
| Open | $86.685 |
|---|---|
| High | $86.97 |
| Low | $85.46 |
| Close | $86.17 |
| Previous close | $87.49 |
| Change | $-1.32 |
| Change % | -1.5087% |
| Volume | 11,156,391 |
| 52-week range | $84.82 - $108.626 |
|---|---|
| 50-day moving average | $94.4508 |
| 200-day moving average | $96.5083 |
| Wall St. target price | $116.26 |
| PE ratio | 36.9156 |
| Dividend yield | $2.15 (2.77%) |
| Earnings per share (TTM) | $2.37 |
Dividend yield: 2.77% of stock value
Forward annual dividend yield: 2.77% of stock value
Dividend payout ratio: 33.61% of net profits
CVS Health has recently paid out dividends equivalent to 2.77% of its share value annually.
CVS Health has paid out, on average, around 33.61% of recent net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 2.77% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), shareholders could enjoy a 2.77% return on their shares, in the form of dividend payments. In CVS Health's case, that would currently equate to about $2.15 per share.
While CVS Health's payout ratio might seem fairly standard, it's worth remembering that it may be investing much of the rest of its net profits in future growth.
CVS Health's most recent dividend payout was on 1 February 2023. The latest dividend was paid out to all shareholders who bought their shares by 19 January 2023 (the "ex-dividend date").
Over the last 12 months, CVS Health's shares have ranged in value from as little as $84.82 up to $108.626. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while CVS Health's is 0.6829. This would suggest that CVS Health's shares are less volatile than average (for this exchange).
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Ever wondered how to buy shares in Blue Water Vaccines? We explain how and compare a range of providers that can give you access to many brands, including Blue Water Vaccines.
Ever wondered how to buy shares in Veru? We explain how and compare a range of providers that can give you access to many brands, including Veru.
Ever wondered how to buy shares in C4 Therapeutics? We explain how and compare a range of providers that can give you access to many brands, including C4 Therapeutics.
Ever wondered how to buy shares in Clever Leaves? We explain how and compare a range of providers that can give you access to many brands, including Clever Leaves.
Ever wondered how to buy shares in NeuroSense Therapeutics? We explain how and compare a range of providers that can give you access to many brands, including NeuroSense Therapeutics.
Mental health stocks can be rewarding, but there are risks involved that could impact your profits. Find out how to invest in companies in the mental health industry.
Pharma stocks can be rewarding, but there are risks involved that could impact your profits. Find out the best way to invest in pharma stock.
Ever wondered how to buy shares in Bone Biologics? We explain how and compare a range of providers that can give you access to many brands, including Bone Biologics.
Ever wondered how to buy shares in Adagio Therapeutics? We explain how and compare a range of providers that can give you access to many brands, including Adagio.
Ever wondered how to buy shares in Bolt Biotherapeutics? We explain how and compare a range of providers that can give you access to many brands, including Bolt Biotherapeutics.
